Shukra Pharmaceuticals Shareholders Approve All Resolutions at 33rd AGM
Shukra Pharmaceuticals Ltd 路 Annual General Meeting 路 30 Sept 2026, 12:12 am
Shukra Pharmaceuticals Shareholders Approve All Resolutions at 33rd AGM Shukra Pharmaceuticals Limited announced the approval of all four resolutions at its 33rd AGM held on 28th Sep'26. Key approvals include the adoption of FY26 audited financial statements with 99.9981% votes in favour, declaration of a final dividend for FY26 with 99.9966% approval, and the re-appointment of executive director Ms. Sanskruti Patel with 99.8574% backing (promoters holding 51.15% were excluded). Additionally, shareholders approved the regularization of Mr. Dinesh Chauhan as an Additional Independent Director via special resolution with 99.9975% affirmative votes.
Original exchange filing (PDF)
More announcements from Shukra Pharmaceuticals Ltd
- Approval for Change of Name of Company on National Stock Exchange Limited dated 16th November 2026 路 17 Nov 2026
- Media Release 路 05 Nov 2026
- Shukra Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 05 Nov 2026
- Reg 32 路 05 Nov 2026
- Unaudited financial results for the quarter ended 30th September 2026 路 05 Nov 2026
- Unaudited financial results for the quarter ended 30th September 2026 路 05 Nov 2026
- SHUKRA PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 04-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 . 路 04 Nov 2026
- The Board Meeting to be held on 03/11/2026 has been revised to 04/11/2026 The Board Meeting to be held on 03/11/2026 has been revised to 04/11/2026 路 04 Nov 2026
